AUPH vs TECH · P/E 28, rev $283.1M vs P/E 65, rev $1.22B
Aurinia Pharmaceuticals Inc (AUPH) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Aurinia Pharmaceuticals Inc (AUPH) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported AUPH revenue for 2025-12-31 was $283.1M. Net income was $287.2M. Revenue was up 372.8% from 2024-12-31 to 2025-12-31. AUPH currently screens at market cap $1.03B and trailing P/E 28.1.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
AUPH currently screens at market cap $1.03B and trailing P/E 28.1. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the AUPH and TECH stock pages for the full models.
Not investment advice.